Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06815146

The Effects of ESP Block and Mid-Transverse Process to Pleura Block on Postoperative Opioid Consumption and Quality of Recovery

Comparison of the Effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on Postoperative Opioid Consumption and Quality of Recovery in Lumbar Spinal Surgery

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) have recently been described for the treatment of pain after lumbar spinal surgery. Although these blocks have been shown to be effective in the treatment of pain after lumbar spinal surgery when compared with postoperative pain, they have not been compared in terms of the quality of recovery and opioid consumption after lumbar spinal surgery. The aim of this clinical trial is to compare the effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on quality of recovery and opioid consumption in patients scheduled for lumbar spinal surgery. The effects of the 2 blocks on postoperative pain will also be compared and recorded.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNumeretic rating scale (NRS)NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.
DIAGNOSTIC_TESTQuality of Results (QoR-40)Several rating scales have been developed to measure quality of recovery after surgery and anaesthesia, but the most extensively used is the QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain.
OTHEROpioid consuptionOpioid consuption will be recorded from PCA

Timeline

Start date
2025-02-15
Primary completion
2026-02-15
Completion
2026-02-15
First posted
2025-02-07
Last updated
2025-02-07

Source: ClinicalTrials.gov record NCT06815146. Inclusion in this directory is not an endorsement.